Recent BTAI News
- BioXcel Therapeutics to Report Third Quarter 2024 Financial Results on November 14, 2024 • GlobeNewswire Inc. • 11/08/2024 12:00:00 PM
- BioXcel Therapeutics to Present at ThinkEquity Conference • GlobeNewswire Inc. • 10/29/2024 11:00:00 AM
- BioXcel Therapeutics Announces U.S. Department of Defense Grant to University of North Carolina to Fund Study of BXCL501 (Sublingual Dexmedetomidine) for Treating Acute Stress Disorder • GlobeNewswire Inc. • 10/15/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/09/2024 08:08:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 01:55:39 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 01:55:12 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/04/2024 01:54:47 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/03/2024 08:40:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/03/2024 08:33:24 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/03/2024 08:17:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 08:05:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2024 11:00:27 AM
- BioXcel Therapeutics Announces Clinical Prioritization and Update on BXCL501 Late-Stage Programs for Agitation • GlobeNewswire Inc. • 09/19/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 11:23:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 11:21:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 11:20:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 11:18:35 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 09/17/2024 11:17:50 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/16/2024 09:42:59 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/16/2024 09:26:07 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/16/2024 09:16:32 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/16/2024 05:23:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 08:15:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2024 11:16:38 AM
- BioXcel Therapeutics Announces Initiation of SERENITY At-Home Pivotal Phase 3 Safety Trial of BXCL501 for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia • GlobeNewswire Inc. • 09/05/2024 11:00:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM